The markers in MMP26, RRM1, SIDT2, and STIM1 align with assorted molecular pathways linked to endothelial dysfunction, inflammation, vascular disease, and numerous SCD-associated complications [44,48,49,53,54] as described in Supplementary Table S1. This evidence concerns the gene SIDT2 and endothelial dysfunction.